Literature DB >> 20670611

Reliable resequencing of the human dystrophin locus by universal long polymerase chain reaction and massive pyrosequencing.

Raoul Jean Pierre Bonnal1, Marco Severgnini, Alessandra Castaldi, Roberta Bordoni, Michele Iacono, Amelia Trimarco, Annalaura Torella, Giulio Piluso, Stefania Aurino, Gianluigi Condorelli, Gianluca De Bellis, Vincenzo Nigro.   

Abstract

The X-linked dystrophin gene is well known for its involvement in Duchenne/Becker muscular dystrophies and for its exceptional megabase size. This locus at Xp21 is prone to frequent random molecular changes, including large deletions and duplications, but also smaller variations. To cope with such huge sequence analysis requirements in forthcoming diagnostic applications, we employed the power of the parallel 454 GS-FLX pyrosequencer to the dystrophin locus. We enriched the genomic region of interest by the robust amplification of 62 fragments under universal conditions by the long-PCR protocol yielding 244,707 bp of sequence. Pooled PCR products were fragmented and used for library preparation and DNA sequencing. To evaluate the entire procedure we analyzed four male DNA samples for sequence coverage and accuracy in DNA sequence variation and for any potential bias. We identified 562 known variations and 55 additional variants not yet reported, among which we detected a causative Arg1844Stop mutation in one sample. Sanger sequencing confirmed all changes. Unexpectedly, only 3 x coverage was sufficient for 99.9993% accuracy. Our results show that long PCR combined to massive pyrosequencing is very reliable for the analysis of the biggest gene of the human genome and open the doors to other demanding applications in molecular diagnostics. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670611     DOI: 10.1016/j.ab.2010.07.022

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods.

Authors:  Irene Corrales; Susana Catarino; Júlia Ayats; David Arteta; Carmen Altisent; Rafael Parra; Francisco Vidal
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients.

Authors:  Marco Savarese; Giuseppina Di Fruscio; Annalaura Torella; Chiara Fiorillo; Francesca Magri; Marina Fanin; Lucia Ruggiero; Giulia Ricci; Guja Astrea; Luigia Passamano; Alessandra Ruggieri; Dario Ronchi; Giorgio Tasca; Adele D'Amico; Sandra Janssens; Olimpia Farina; Margherita Mutarelli; Veer Singh Marwah; Arcomaria Garofalo; Teresa Giugliano; Simone Sampaolo; Francesca Del Vecchio Blanco; Gaia Esposito; Giulio Piluso; Paola D'Ambrosio; Roberta Petillo; Olimpia Musumeci; Carmelo Rodolico; Sonia Messina; Anni Evilä; Peter Hackman; Massimiliano Filosto; Giuseppe Di Iorio; Gabriele Siciliano; Marina Mora; Lorenzo Maggi; Carlo Minetti; Sabrina Sacconi; Lucio Santoro; Kathleen Claes; Liliana Vercelli; Tiziana Mongini; Enzo Ricci; Francesca Gualandi; Rossella Tupler; Jan De Bleecker; Bjarne Udd; Antonio Toscano; Maurizio Moggio; Elena Pegoraro; Enrico Bertini; Eugenio Mercuri; Corrado Angelini; Filippo Maria Santorelli; Luisa Politano; Claudio Bruno; Giacomo Pietro Comi; Vincenzo Nigro
Journal:  Neurology       Date:  2016-06-08       Impact factor: 9.910

3.  Next generation sequencing (NGS) strategies for the genetic testing of myopathies.

Authors:  Vincenzo Nigro; Giulio Piluso
Journal:  Acta Myol       Date:  2012-12

Review 4.  Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives.

Authors:  Vincenza Precone; Valentina Del Monaco; Maria Valeria Esposito; Fatima Domenica Elisa De Palma; Anna Ruocco; Francesco Salvatore; Valeria D'Argenio
Journal:  Biomed Res Int       Date:  2015-11-19       Impact factor: 3.411

5.  Molecular diagnosis of Usher syndrome: application of two different next generation sequencing-based procedures.

Authors:  Danilo Licastro; Margherita Mutarelli; Ivana Peluso; Kornelia Neveling; Nienke Wieskamp; Rossella Rispoli; Diego Vozzi; Emmanouil Athanasakis; Angela D'Eustacchio; Mariateresa Pizzo; Francesca D'Amico; Carmela Ziviello; Francesca Simonelli; Antonella Fabretto; Hans Scheffer; Paolo Gasparini; Sandro Banfi; Vincenzo Nigro
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.